Close Menu

This article has been updated from a previous version to provide additional information on Qiagen's 2016 organic growth drivers and comments from a company earnings call.

NEW YORK (GenomeWeb) – Qiagen reported after the close of the market Wednesday that its fourth quarter revenues grew 5 percent year over year, falling short of Wall Street expectations due largely to currency headwinds.

For the three months ended Dec. 31, Qiagen posted revenues of $366.5 million compared to $348.5 million a year ago. On average, analysts had expected revenues of $370.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Apr
23
Sponsored by
N-of-One

In 2016, the Association for Molecular Pathology (AMP), in partnership with the College of American Pathologists (CAP) and American College of Molecular Genetics (ACMG), launched a set of guidelines meant to set industry standards for reporting of molecular diagnostic test results in oncology, using a tier-based system and defined levels of evidence. 

Apr
24
Sponsored by
Biocrates

This webinar will provide a wide-ranging overview of the promise for metabolomics in studying human health and disease, as well as its potential for integration with other -omics disciplines.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.